| __timestamp | Corcept Therapeutics Incorporated | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 26551000 | 2819557000 |
| Thursday, January 1, 2015 | 50286000 | 4103728000 |
| Friday, January 1, 2016 | 81321000 | 4860427000 |
| Sunday, January 1, 2017 | 159201000 | 5872227000 |
| Monday, January 1, 2018 | 251247000 | 6710800000 |
| Tuesday, January 1, 2019 | 306486000 | 7863400000 |
| Wednesday, January 1, 2020 | 353874000 | 8497100000 |
| Friday, January 1, 2021 | 365978000 | 16071700000 |
| Saturday, January 1, 2022 | 401858000 | 12172900000 |
| Sunday, January 1, 2023 | 482375000 | 13117200000 |
| Monday, January 1, 2024 | 14202000000 |
Unleashing insights
In the competitive landscape of biotechnology, revenue growth is a key indicator of success. Over the past decade, Regeneron Pharmaceuticals, Inc. has consistently outperformed Corcept Therapeutics Incorporated in annual revenue. Starting in 2014, Regeneron's revenue was approximately 100 times that of Corcept, and by 2023, it had grown to nearly 27 times more. This impressive growth trajectory highlights Regeneron's dominance in the sector.
From 2014 to 2023, Regeneron's revenue surged by over 360%, peaking at around $13 billion in 2023. In contrast, Corcept's revenue, while growing steadily, increased by approximately 1,700%, reaching nearly $500 million in the same year. This stark contrast underscores Regeneron's robust market position and innovative prowess.
As both companies continue to innovate, the revenue gap may narrow. However, Regeneron's current lead sets a high benchmark for Corcept to aspire to.
Revenue Insights: AstraZeneca PLC and Regeneron Pharmaceuticals, Inc. Performance Compared
Breaking Down Revenue Trends: AstraZeneca PLC vs Corcept Therapeutics Incorporated
Breaking Down Revenue Trends: Pfizer Inc. vs Regeneron Pharmaceuticals, Inc.
Comparing Revenue Performance: Regeneron Pharmaceuticals, Inc. or Alnylam Pharmaceuticals, Inc.?
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Genmab A/S
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated's Expenses
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated
Comparing Revenue Performance: Regeneron Pharmaceuticals, Inc. or Amneal Pharmaceuticals, Inc.?
Revenue Showdown: Alnylam Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated or Telix Pharmaceuticals Limited: Who Leads in Yearly Revenue?
Who Generates More Revenue? Corcept Therapeutics Incorporated or ImmunityBio, Inc.
Revenue Showdown: Corcept Therapeutics Incorporated vs MiMedx Group, Inc.